DiscovermedAI Times
medAI Times
Claim Ownership

medAI Times

Author: medAI Times

Subscribed: 0Played: 0
Share

Description

medAI Times is a daily podcast on artificial intelligence in medicine. Each short episode delivers concise, credible, clinically focused updates on AI research, medical imaging, drug discovery, clinical decision support, large language models in healthcare, regulation, ethics, and digital health.

Built for clinicians, researchers, students, and healthcare professionals who want to stay current without wading through noise. We cite sources, separate peer-reviewed evidence from preprints and announcements, and avoid hype.

New episodes daily.

For educational and informational purposes only. Not medical advice.
37 Episodes
Reverse
Five billion dollars for AI drugs, and not one has reached a patient yet.Run time: 6:38In today's episode:Isomorphic raises $5B; still no drug in human trialsVanderbilt AURA trial cuts autoimmune diagnosis wait 138 to 43 daysAlphaGenome 2 doubles causal-variant hits, per company preprintFOLLOW-UP: AHA's WATCH-LV: smartwatch brands disagree on 9%OpenAI sends computer-use agents into ChatGPT for HealthcareApple and OpenEvidence open 200,000-person health AI studyFDA swaps "artificial intelligence" for "super intelligence"GE clears on-device feeding-tube AI for portable X-rayFOLLOW-UP: NEJM AI chest X-ray fracture model, densitometry-referred caveatAnthropic prices record $81B IPO, trades as ANTGoogle ships Gemini 4 Neon at $3/$15 per million tokensOpenAI GPT-6.2 lands to mixed early-tester reviewsTL;DR:Isomorphic Labs raised $5B (Nov 17) on top of a $2.1B round six months ago. No candidate has entered human trials, and every result so far is preclinical and self-reported.AURA (NEJM AI, Nov 6) is the week's real evidence: 2,385 ANA-positive patients randomized at Vanderbilt. Median time to diagnosis fell from 138 to 43 days (HR 1.9).Anthropic went public on Nov 19 at $83 a share, about $81.3B of stock. Its company-published biology claims now sit under public-market incentives, so outside replication matters more.Sources cited:pharmaphorumNEJM AI / PubMedGoogle DeepMindbioRxiv preprintAHA NewsroomFierce HealthcareMobiHealthNewsRAPSFDA noticeZenopaSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
Should a chatbot ever help you stop a seizure medication? A lawsuit says it did.Run time: 6:21In today's episode:Parents sue OpenAI, alleging ChatGPT guided daughter off epilepsy medicationJAMA: most updated AI devices changed their intended useGenerative AI maternal-health chatbot shows no benefit in RCTCassidy draft bill would test Medicare pay for autonomous AIColumbia: AI message drafts help only when actually usedStony Brook: reviewers preferred AI discharge summaries in 95 percentBMJ study: chatbots steer users to for-profit stem-cell clinicsAnthropic reports Claude-assisted vault protein work, preprint onlyMETR: Anthropic's model progress roughly doubled, evidence mostly redactedOpenAI opens gated GPT-6 Rosalind Research to enterprise customersathenahealth lets patients share their records with ClaudeTL;DR:A wrongful-death suit (filed Oct 27) alleges GPT-4o went along with an epilepsy patient's plan to come off her antiseizure medication; these are allegations, not findings, but medication-change requests are a testable failure point.JAMA Network Open (Nov 5): 56 of 163 FDA-cleared AI devices were updated, about three in four of those updates changed how the device is used, and 85.7% offered no clinical-benefit evidence.Two null-or-mixed results worth reading: the Rosie maternal chatbot RCT (no 12-month effect) and Columbia's draft-reply study (slower overall, faster when a draft is actually used).Sources cited:The Next WebJAMA Network OpenJAMA Network OpenMedical DailyJAMA Network OpenNews-MedicalMedical XpressAnthropicMETRall-ai.deSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
Claude designed three hundred thousand proteins in sixty-four hours. Seventeen worked.Run time: 6:30In today's episode:Claude designs 17 scorpion toxin binders; no antivenom yetOpenAI swarm of 2,000 agents mines mouse brain atlasFace-photo AI predicts cancer survival in Lancet Digital HealthFDA clears TumorSight Risk for breast recurrence estimatesFDA clears Elucid FFR-IQ for CT-based coronary flowAstraZeneca-insitro deal: $40M upfront, $1.5B headlineFDA generative AI device comment window closesAnthropic opens Claude Duet agent to waitlistAnthropic draft IPO papers leak revenue and lossTL;DR:Claude's scorpion-toxin binders are real lab hits (17 of 211) but only binding data: no neutralization, no venom, no animals.OpenAI's agent swarm produced a DCTN1-cholesterol lead from a mouse brain atlas; preprint, company-authored, unconfirmed at the bench.Two FDA clearances (TumorSight Risk, Elucid FFR-IQ) rest on company validation that shows consistency, not outcome benefit.Sources cited:AnthropicThe DecoderbioRxiv preprintpress releaseTech TimesNews-MedicalFox affiliate report of company releaseCardiovascular BusinessFierce BiotechFDASubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
Eight states just took ChatGPT to court, and medical advice is in the complaint.Run time: 7:07In today's episode:Eight states sue OpenAI; the FTC sends demands to OpenAI and AnthropicChatbots miss GI emergencies far more often outside EnglishPenn patients text their EEG monitors in Nature MedicineDeepMind agent finds an antibiotic candidate; wet lab pendingZealand pays Generate $30M up front for AI-designed proteinsOpenEvidence goes live in Northwestern's Epic and signs HopkinsUnitedHealth says AI chart summaries reach 40% of its cliniciansFOLLOW-UP: UK accepts all 44 health AI regulation recommendationsMeta releases Muse Spark Open, 816B open weightsNEW: Anthropic embeds six METR evaluators with publication rightsTL;DR:Eight states (October 14) and the FTC (October 14, reported October 15) moved against frontier chatbot makers in the same 24 hours. The states' complaints name harmful medical guidance and a claimed overdose. All of it is allegation so far.An ACG abstract found four small chatbots failed to advise emergency care in 15% of English answers and about 40% of Chinese and Vietnamese ones. It's the most clinically useful number of the week, from the weakest kind of source.The week's AI biology "discovery" (DeepMind's bacteriocin) is computational only. The AI drug money (Zealand and Generate) is real, but $30M of it is up front and the rest is milestones.Sources cited:EngadgetThe New DailyGizmodo (FTC)HealioPenn MedicineGoogle DeepMindBioSpaceHealthcare IT NewsNorthwesternUnite.AI (Hopkins)Subscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
Can a chatbot safely interview real patients before the doctor does? Google just tested it.Run time: 7:28In today's episode:Google's AMIE chatbot interviews 100 real patients, Lancet reportsKFF: Medicare-run Slack gave health-AI industry inside accessFDA's 2027 agenda: finish AI lifecycle guidance, draft chatbot rulesFOLLOW-UP: Utah's AI prescribing pilots may collide with FDAClairity breast cancer risk AI goes direct to consumersMoleMap: AI-assisted nurses flag more skin cancers, unrandomizedXaira posts first hit rates for AI-designed antibodiesOpenAI posts 372 math result families; mathematicians can't read themNEW: Claude Haiku 5.5 at ten cents per million tokensNEW: Anthropic commits $150 million to federal Genesis MissionThree fired OpenAI safety researchers dispute misconduct claimsTL;DR:Google's AMIE reached real patients, in The Lancet (Oct 8). 100 adults at a Beth Israel Deaconess urgent primary care clinic, a physician watching every chat, zero safety stops, final diagnosis in the differential 90% of the time. Single arm, single centre: feasibility, not benefit.OpenAI published 372 families of AI-generated math results (Oct 6), including a claimed proof of the Unique Games Conjecture. About 42% of top-line results are Lean-checked, and the people best placed to read the proofs say they can't yet.Health-AI policy is being shaped in rooms the public can't see. KFF Health News (Oct 9) documents a 1,700-member CMS-run Slack and an unlisted FDA listening session on patient chatbots, the same week the FDA put generative-AI mental health devices on its 2027 guidance agenda.Sources cited:The LancetGoogle blogpreprint, arXiv 2603.08448KFF Health NewsCBS NewsMedTech DiveRAPSSTATHealth Affairs Forefront backgroundEverlywell release via Yahoo FinanceSubscribe: YouTubemedAI Times is for educational and informational purposes only. The content does not constitute medical advice, diagnosis, treatment recommendation, or professional clinical guidance. Consult qualified healthcare professionals and refer to official sources before making clinical, research, regulatory, or business decisions.
loading
Comments